Skip to main content
76°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Verrica Pharmaceuticals Inc. - Common Stock
(NQ:
VRCA
)
0.5243
-0.0164 (-3.03%)
Streaming Delayed Price
Updated: 2:22 PM EDT, Jun 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Verrica Pharmaceuticals Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
May 28, 2025
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
Verrica Pharmaceuticals Reports Quarterly 2025 Financial Results
May 13, 2025
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
Earnings Outlook For Verrica Pharmaceuticals
May 12, 2025
Via
Benzinga
Verrica Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 13, 2025
May 07, 2025
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
Earnings Scheduled For May 13, 2025
May 13, 2025
Via
Benzinga
Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York
April 30, 2025
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
April 25, 2025
Via
Benzinga
Verrica Pharmaceuticals Reports Strong Demand-Led Growth in YCANTH® Dispensed Applicator Units in First Quarter 2025
April 07, 2025
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
April 04, 2025
Via
Benzinga
Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors
April 02, 2025
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
Verrica Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
March 31, 2025
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer
March 26, 2025
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
March 11, 2025
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
Earnings Scheduled For March 11, 2025
March 11, 2025
Via
Benzinga
Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 11, 2025
March 03, 2025
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
Verrica Pharmaceuticals to Participate in the TD Cowen 45th Annual Health Care Conference in Boston
February 25, 2025
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
Optimism in War on Cancer on the Rise, as Biotech Companies Roll Out More Wins
February 18, 2025
Vancouver, BC – February 18, 2025 – USA News Group News Commentary – Despite optimism coming from the launch of Project Stargate (a $500 billion investment in AI data centers), there is still cause for...
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Verrica Pharmaceuticals Announces Presentation of Three Posters Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2025 Winter Clinical Dermatology Conference
January 21, 2025
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
Verrica Provides Business and Operational Update
December 20, 2024
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
Verrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 09, 2024
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
Verrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan
December 06, 2024
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
Verrica Announces Pricing of $42.0 Million Public Offering
November 21, 2024
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
Verrica Announces Proposed Public Offering
November 20, 2024
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
This Super Micro Computer Analyst Turns Bearish; Here Are Top 5 Upgrades For Wednesday
November 06, 2024
Via
Benzinga
Dow Jumps 400 Points; Yum! Brands Posts Downbeat Earnings
November 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
S&P 500 Gains 1%; Vimeo Shares Spike Higher
November 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 05, 2024
Via
Benzinga
Nasdaq Gains Over 100 Points; US Trade Deficit Widens In September
November 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 05, 2024
Via
Benzinga
Why Palantir Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
November 05, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
